Log In
BCIQ
Print this Print this
 

VTP-38543

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionLiver X receptor beta (NR1H2; LXR-b) agonist
Molecular Target Liver X receptor beta (NR1H2) (LXR-b)
Mechanism of ActionLiver X receptor (LXR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat mild to moderate atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$639.0M

$639.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/25/2016

$639.0M

$639.0M

0

Get a free BioCentury trial today